Search
for
Sort by
Research 601–630 of 1000+
- Inflammatory Cytokine TNFα Promotes the Long-Term Expansion of Primary Hepatocytes in 3D Culture
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Epidermal stem cells: skin surveillance and clinical perspective
- Dual effects of human adipose tissue-derived mesenchymal stem cells in human lung adenocarcinoma A549 xenografts and colorectal adenocarcinoma HT-29 xenografts in mice
- Control of myeloid cell density in barrier tissues
- Fish Acellular Dermal Matrix Promotes Repair of Full‐Thickness Skin Defects in Mice and Bama Pigs
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- The correlation between corona virus disease 2019 and alopecia areata: a literature review
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- The Biology and Genomics of Human Hair Follicles: A Focus on Androgenetic Alopecia
- MCPIP1 controls effects of myeloid cells on skin carcinogenesis and hair growth
- Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cells
- 1323 The effects of 3-OH of kaempferol on interfollicular epidermal stem cell fate
- 1327 Effect of ginsenoside Rd on dermal epidermal junction in fibroblast
- 1325 Age-dependent loss of the stemness and antimicrobial defense function of dermal fibroblasts is mediated by TGFbeta
- Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells
- MicroRNA in skin diseases
- Ritlecitinib in severe alopecia areata: a profile of its use
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Epigenetic regulation in adult stem cells and cancers
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- Fast clinical response with topical ruxolitinib in the management of non-segmental vitiligo detected by VISIA<sup>®</sup> analysis system
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Analysis of histology and long noncoding RNAs involved in the rabbit hair follicle density using RNA sequencing
- Aromatic plants as cosmeceuticals: benefits and applications for skin health
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review